Health Care & Life Sciences » Pharmaceuticals | Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
8,957.60
2,293.40
1,896.20
4,051.30
44,637.00
20,484
Total Accounts Receivable
18,564.70
27,968.60
24,820.40
73,337.70
27,298.00
57,990
Inventories
4,543.60
3,323.60
4,163.00
5,092.40
4,622.00
3,369
Other Current Assets
1,375.90
1,164.90
1,190.50
988.90
1,846.00
1,636
Total Current Assets
33,441.80
34,750.50
32,070.00
83,470.30
78,403.00
83,478
Net Property, Plant & Equipment
111,844.20
98,127.40
94,108.50
108,980.10
107,587.00
155,611
Total Investments and Advances
2,004.70
1,657.10
2,746.10
2,389.90
1,651.00
62,562
Long-Term Note Receivable
76.80
299.50
254.10
324.20
-
-
Other Assets
13,025.20
12,294.40
17,611.60
19,146.10
17,276.00
25,927
Total Assets
174,071.50
158,862.50
157,896.30
225,220.10
204,917.00
327,579
ST Debt & Current Portion LT Debt
27,920.50
7,930.20
22,711.20
34,418.30
-
Accounts Payable
51,290.10
56,460.60
59,903.00
71,387.90
55,811.00
Other Current Liabilities
71,090.00
33,678.70
10,549.50
14,898.70
23,374.00
Total Current Liabilities
150,300.70
98,069.50
93,163.60
120,705.00
79,185.00
Long-Term Debt
60,161.60
52,835.00
10,515.00
7,185.30
-
Provision for Risks & Charges
3,326.20
4,074.20
4,667.80
5,523.50
4,640.00
Other Liabilities
-
-
-
-
1.00
Total Liabilities
227,467.10
166,712.20
119,452.60
144,323.50
83,824.00
Common Equity (Total)
54,964.50
9,418.60
36,874.90
79,327.80
121,093.00
Total Shareholders' Equity
54,964.50
9,418.60
36,874.90
79,327.80
121,093.00
Total Equity
54,964.50
9,418.60
36,874.90
79,327.80
121,093.00
Liabilities & Shareholders' Equity
174,071.50
158,862.50
157,896.30
225,220.10
204,917.00
Non-Equity Reserves
1,568.90
1,568.90
1,568.90
1,568.90
-

About Gujarat Themis Biosyn

View Profile
Address
Themis House
Mumbai Maharashtra 400104
India
Employees -
Website http://www.gtbl.in
Updated 07/08/2019
Gujarat Themis Biosyn Ltd. is a pharmaceutical company, which engages in the manufacture of drugs. Its products include Rifamycin and Lovastatin. The company was founded on December 11, 1981 and is headquartered in Mumbai, India.